Last week, the drug company Merck & Co announced positive results regarding its new anti-viral Covid-19 pill. Data showed the pill cut the chances of dying or being hospitalized for at-risk populations in half, a major development in the fight again the virus since the release of the vaccines. However, Dr. Marty Makary, a professor of surgery and health policy at the Johns Hopkins University School of Medicine said that Merck is being cautious about promoting the experimental new drug over the fear of backlash from the Food and Drug Administration (FDA).

Fox News host Bian Kilmeade asked Dr. Makary directly why the company “isn’t going to bat” for its own drug, and the response is shocking.

Townhall reports:

“Well, they’ve got to be very careful with the FDA,” Makary responded. “If you do something out of line with what they want you could offend them and the FDA is vindictive and they will hold up authorizations and approvals.”

“Are you kidding? The FDA is vindictive?” he asked.

“First of all this is the most political FDA in U.S. history,” Makary claimed. “Second of all, the FDA has a long history of pulling products from companies that are unrelated to mistakes in other medication and device applications so companies have to be very careful, and that’s why you generally don’t see pharma complaining about the bureaucracy and red tape at the FDA—”

Kilmeade cut straight to the point and asked if drug companies, including Merck, are “afraid” of the FDA.

Dr. Makary responded, “Yeah, they’re afraid of the backlash.”

It seems those like Dr. Fauci and the FDA are determined to keep the pandemic going forever.